Articles written by: Carolyn Fisher

Sierra Bancorp (BSRR)’s Financial Results Comparing With Bank of Hawaii Corporation (NYSE:BOH)

As Regional – Pacific Banks businesses, Sierra Bancorp (NASDAQ:BSRR) and Bank of Hawaii Corporation (NYSE:BOH), are affected by compare. This especially applies to their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sierra Bancorp […]

Bain Capital Specialty Finance Inc. (BCSF)’s Financial Results Comparing With Delaware Investments National Municipal Income Fund (NYSEAMERICAN:VFL)

This is a contrast between Bain Capital Specialty Finance Inc. (NYSE:BCSF) and Delaware Investments National Municipal Income Fund (NYSEAMERICAN:VFL) based on their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership. The two companies are Asset Management and they also compete with each other. Earnings and Valuation Gross Revenue […]

Contrasting of Progenics Pharmaceuticals Inc. (PGNX) and Merrimack Pharmaceuticals Inc. (NASDAQ:MACK)

As Biotechnology companies, Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) and Merrimack Pharmaceuticals Inc. (NASDAQ:MACK) are our subject to compare. And more specifically their profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Progenics Pharmaceuticals Inc. 15.62M 23.22 […]

Contrasting of Eaton Vance Municipal Bond Fund II (EIV) and Pioneer Diversified High Income Trust (NYSEAMERICAN:HNW)

Since Eaton Vance Municipal Bond Fund II (NYSEAMERICAN:EIV) and Pioneer Diversified High Income Trust (NYSEAMERICAN:HNW) are part of the Asset Management industry, they are influenced by compare. The influences particularly affect the analyst recommendations, profitability, institutional ownership, risk, dividends, earnings and valuation of both companies. Valuation & Earnings Gross Revenue […]

Reviewing TRACON Pharmaceuticals Inc. (TCON)’s and Incyte Corporation (NASDAQ:INCY)’s results

TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Incyte Corporation (NASDAQ:INCY) are two firms in the Biotechnology that compete against each other. Below is a comparison of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TRACON […]

VIVUS Inc. (VVUS) and Aileron Therapeutics Inc. (NASDAQ:ALRN) Comparison side by side

Since VIVUS Inc. (NASDAQ:VVUS) and Aileron Therapeutics Inc. (NASDAQ:ALRN) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect the risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation of both companies. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Contrasting of Neuberger Berman California Intermediate Municipal Fund Inc. (NBW) and Pzena Investment Management Inc (NYSE:PZN)

Both Neuberger Berman California Intermediate Municipal Fund Inc. (NYSEAMERICAN:NBW) and Pzena Investment Management Inc (NYSE:PZN) compete on a level playing field in the Asset Management industry. We will evaluate their performance with regards to dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership. Earnings & Valuation Gross Revenue Price/Sales […]

Comparing of GAMCO Natural Resources Gold & Income Trust (GNT) and SEI Investments Co. (NASDAQ:SEIC)

We will be comparing the differences between GAMCO Natural Resources Gold & Income Trust (NYSE:GNT) and SEI Investments Co. (NASDAQ:SEIC) as far as risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation are concerned. The two businesses are rivals in the Asset Management industry. Earnings & Valuation Gross Revenue […]

Marker Therapeutics Inc. (MRKR)’s Financial Results Comparing With MorphoSys AG (NASDAQ:MOR)

Both Marker Therapeutics Inc. (NASDAQ:MRKR) and MorphoSys AG (NASDAQ:MOR) are Biotechnology companies, competing one another. We will contrast their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Marker Therapeutics Inc. N/A 1380.98 147.96M -1.28 […]

Kodiak Sciences Inc. (KOD) and CymaBay Therapeutics Inc. (NASDAQ:CBAY) Contrasting side by side

Kodiak Sciences Inc. (NASDAQ:KOD) and CymaBay Therapeutics Inc. (NASDAQ:CBAY), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influence the risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation of the two firms. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income […]